본문 바로가기
KERD
논문KCI 등재

The Clinical Guidelines for Acute Uncomplicated Cystitis and Acute Uncomplicated Pyelonephritis

이선주|이승주|최훈|정홍|정재민|김재헌|최현섭|정재흥|김기호
대한요로생식기감염학회|2017.08|Urogenital Tract Infection|제12권 제2호|pp. 55-64

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

GuidelineUrinary tract infectionsPyelonephritisCystitis
주제분류비뇨기과학

초록

To date, there has not been an establishment of guidelines for urinary tract infections, due to limited domestic data in Korea, unlike other North American and European countries. The clinical characteristics, etiology, and antimicrobial susceptibility of urinary tract infections vary from country to country. Moreover, despite the same disease, antibiotic necessary to treat it may vary from country to country. Therefore, it is necessary to establish a guideline that is relevant to a specific country. However, in Korea, domestic data have been limited, and thus, guidelines considering the epidemiological characteristics pertaining specifically to Korea do not exist. Herein, describe a guideline that was developed by the committee of The Korean Association of Urogenital Tract Infection and Inflammation, which covers only the uncomplicated urinary tract infections, as covering all parts in the first production is difficult.

Abstract

To date, there has not been an establishment of guidelines for urinary tract infections, due to limited domestic data in Korea, unlike other North American and European countries. The clinical characteristics, etiology, and antimicrobial susceptibility of urinary tract infections vary from country to country. Moreover, despite the same disease, antibiotic necessary to treat it may vary from country to country. Therefore, it is necessary to establish a guideline that is relevant to a specific country. However, in Korea, domestic data have been limited, and thus, guidelines considering the epidemiological characteristics pertaining specifically to Korea do not exist. Herein, describe a guideline that was developed by the committee of The Korean Association of Urogenital Tract Infection and Inflammation, which covers only the uncomplicated urinary tract infections, as covering all parts in the first production is difficult.

참고문헌 (47)

  1. Stamm WE, "Management of urinary tract infections in adults", N Engl J Med, 329, pp.1328~1334 (1993)
  2. Bradbury SM, "Collection of urine specimens in general practice: to clean or not to clean?", J R Coll Gen Pract, 38, pp.363~365 (1988)
  3. Lifshitz E, "Outpatient urine culture: does collection technique matter?", Arch Intern Med, 160, pp.2537~2540 (2000)
  4. Foxman B, "Epidemiology of urinary tract infections:transmission and risk factors, incidence, and costs", Infect Dis Clin North Am, 17, pp.227~241 (2003)
  5. Fihn SD, "Clinical practice. Acute uncomplicated urinary tract infection in women", N Engl J Med, 349, pp.259~266 (2003)
  6. Gupta K, "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women:a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases", Clin Infect Dis, 52, pp.e103~e120 (2011)
  7. Kim ME, "Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006", Int J Antimicrob Agents, 31(Suppl 1), pp.S15~S18 (2008)
  8. Lee SJ, "Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System", J Infect Chemother, 17, pp.440~446 (2011)
  9. Rafalsky V, "Quinolones for uncomplicated acute cystitis in women", Cochrane Database Syst Rev, (3), pp.CD003597~ (2006)
  10. Nicolle LE, "Pivmecillinam in the treatment of urinary tract infections", J Antimicrob Chemother, 46(Suppl 1), pp.35~39 (2000)
  11. Gupta K, "Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women", Arch Intern Med, 167, pp.2207~2212 (2007)
  12. Warren JW, "Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women", Clin Infect Dis, 29, pp.745~758 (1999), Infectious Diseases Society of America
  13. Gupta K, "Outcomes associated with trimethoprim", sulphamethoxazole (TMP, SMX resistant community-acquired UTI, pp.Int J Antimicrob Agents, 2002[DOI]
  14. Nicolle LE, "Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults", Clin Infect Dis, 40, pp.643~654 (2005)
  15. Karlowsky JA, "Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study", Antimicrob Agents Chemother, 50, pp.2251~2254 (2006)
  16. Zhanel GG, "Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)", Int J Antimicrob Agents, 27, pp.468~475 (2006)
  17. 위성헌, "2001년부터 2006년까지 지역사회 획득 급성 신우신장염 여성환자의 임상상 및 원인균의 내성 양상", Infection and Chemotherapy, 49(1), pp.9~16 (2007), 대한감염학회
  18. Ki M, "The epidemiology of acute pyelonephritis in South Korea, 1997-1999", Am J Epidemiol, 160, pp.985~993 (2004)
  19. 이동기, "Acute Pyelonephritis: Clinical Characteristics and the Role of the Surgical Treatment", Journal of Korean Medical Science, 24(2), pp.296~301 (2009), 대한의학회
  20. Lee DS, "Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010-2011", Antimicrob Agents Chemother, 57, pp.5384~5393 (2013)
  21. Scholes D, "Risk factors associated with acute pyelonephritis in healthy women", Ann Intern Med, 142, pp.20~27 (2005)
  22. Busch R, "Correlation of symptoms and results of direct bacterial localization in patients with urinary tract infections", J Urol, 132, pp.282~285 (1984)
  23. King C, "Risk factors for healthcare-associated urinary tract infection and their applications in surveillance using hospital administrative data: a systematic review", J Hosp Infect, 82, pp.219~226 (2012)
  24. 정연환, "급성신우신염 환자의 다기관 특성비교", Investigative and Clinical Urology, 48(1), pp.29~34 (2007), 대한비뇨기과학회
  25. 황병연, "서울 강서지역 1개 대학병원에서 성인 급성 신우신염의 원인균과 항생제 감수성", Infection and Chemotherapy, 35(5), pp.277~282 (2003), 대한감염학회
  26. Wie SH, "Antibiotic sensitivity of the causative organisms and use of antibiotics in women with community-acquired acute pyelonephritis", Korean J Infect Dis, 34, pp.353~359 (2002)
  27. Park JH, "Serum procalcitonin level for the prediction of severity in women with acute pyelonephritis in the ED: value of procalcitonin in acute pyelonephritis", Am J Emerg Med, 31, pp.1092~1097 (2013)
  28. Ha YE, "Diagnostic usefulness of procalcitonin as a marker of bacteremia in patients with acute pyelonephritis", Scand J Clin Lab Invest, 73, pp.444~448 (2013)
  29. Velasco M, "Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary?", Clin Infect Dis, 37, pp.1127~1130 (2003)
  30. Mitterberger M, "Acute pyelonephritis: comparison of diagnosis with computed tomography and contrast-enhanced ultrasonography", BJU Int, 101, pp.341~344 (2008)
  31. Browne RF, "Imaging of urinary tract infection in the adult", Eur Radiol, 14(Suppl 3), pp.E168~E183 (2004)
  32. Paick SH, "Clinical value of acute pyelonephritis grade based on computed tomography in predicting severity and course of acute pyelonephritis", J Comput Assist Tomogr, 37, pp.440~442 (2013)
  33. Ha SK, "Acute pyelonephritis focusing on perfusion defects on contrast enhanced computerized tomography(CT) scans and its clinical outcome", Korean J Intern Med, 12, pp.122~127 (1997)
  34. Naber KG, "Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC):implications for empiric therapy", Eur Urol, 54, pp.1164~1175 (2008)
  35. Talan DA, "Comparison of ciprofloxacin (7 days) and trimethoprimsulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial", JAMA, 283, pp.1583~1590 (2000)
  36. Klausner HA, "A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and", or 500 mg twice daily for 10days in the treatment of acute pyelonephritis, 2007, pp.23, 2637~2645
  37. Peterson J, "A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400", 500 mg twicedaily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis, 2008, pp.71, 17~22
  38. Cronberg S, "Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime", Scand J Infect Dis, 33, pp.339~343 (2001)
  39. Colgan R, "Diagnosis and treatment of acute uncomplicated cystitis", Am Fam Physician, 84, pp.771~776 (2011)
  40. Stamm WE, "Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial", Ann Intern Med, 106, pp.341~345 (1987)
  41. Richard GA, "Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis", Urology, 52, pp.51~55 (1998)
  42. Rubin RH, "Evaluation of new anti-infective drugs for the treatment of urinary tract infection", Clin Infect Dis, 15(Suppl 1), pp.S216~S227 (1992)
  43. Wells WG, "Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy", J Antimicrob Chemother, 53(Suppl 2), pp.ii67~ii74 (2004)
  44. Mouton YJ, "Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group", J Antimicrob Chemother, 36(Suppl A), pp.145~156 (1995)
  45. Giamarellou H, "Low-dosage cefepime as treatment for serious bacterial infections", J Antimicrob Chemother, 32(Suppl B), pp.123~132 (1993)
  46. Naber KG, "Piperacillin 2 g", tazobactam 0.5 g is as effective as imipenem 0.5 g, Int J Antimicrob Agents, pp.2002, 19[DOI]
  47. Naber KG, "Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis", Antimicrob Agents Chemother, 53, pp.3782~3792 (2009)

관련 논문AI추천

Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections강철인, 김백남, 김지은, 민승기, 박대원, 여정균, 위성헌, 이승주, 이희영, 하유신대한감염학회 · Infection and Chemotherapy2018 · 제50권 제1호요로 감염 임상진료지침 권고안: 무증상 세균뇨, 단순 요로감염, 복잡성 요로감염, 세균성 전립선염대한감염학회, 대한화학요법학회, 대한임상미생물학회, 대한요로생식기감염학회대한감염학회 · Infection and Chemotherapy2011 · 제43권 제1호2017 Guidelines of The Korean Association of Urogenital Tract Infection and Inflammation: Acute Uncomplicated Cystitis정홍, 최훈, 김기호, 김재헌, 나용길, 이선주, 이승주, 정재민, 정재흥, 조용현, 최현섭대한요로생식기감염학회 · Urogenital Tract Infection2017 · 제12권 제1호국내에서 지역사회 급성 신우신염 원인균의 항균제 감수성 결과에 근거하여 지역사회 급성 방광염 치료 항균제를 선택할 수 있는가?이혁, 권기태, 김봉영, 김지은, 류성열, 박대원, 박선희, 배현주, 신상엽, 염준섭, 위성헌, 이진서, 임승관, 정문현, 정희진, 조용균대한감염학회 · Infection and Chemotherapy2012 · 제44권 제4호National Trends of Antimicrobial Resistance in Uncomplicated Cystitis이승주, 최현섭대한요로생식기감염학회 · Urogenital Tract Infection2016 · 제11권 제1호2017 Guidelines of The Korean Association of Urogenital Tract Infection and Inflammation: Recurrent Urinary Tract Infection정홍, 최훈, 김기호, 김재헌, 나용길, 이선주, 이승주, 정재민, 정재흥, 조용현, 최현섭대한요로생식기감염학회 · Urogenital Tract Infection2017 · 제12권 제1호

이 간행물의 다른 논문 (4건)

Genetic Variation in Mycoplasma genitalium이길호pp. 65-76The Antibiotic Susceptibility of Escherichia coli from Community-Acquired Uncomplicated Urinary Tract Infection: A Focused on Fosfomycin윤하나, 장인호, 김기호, 이선주, 이상돈, 이미경, 김태형, 이승주, 민승기, 정홍, 정재민, 정재흥, 최현섭, 나용길, 유호송pp. 77-81The Risk Factors of Recurrent Febrile Urinary Tract Infection within 1 Year in Urinary Stone Patients with Acute Obstructive Pyelonephritis윤솔, 화정석, 현재석, 이신우, 도정모, 서덕하, 이춘우, 정규현, 제성욱, 최시민, 감성철pp. 82-88Type Distribution of Human Papillomavirus in Genital Warts of Korean Men정태영, 조정호, 류경호, 이민정pp. 89-94
원문 보기